These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 22613584

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Long-term results of surgical treatment of secondary severe mitral regurgitation in patients with end-stage heart failure: Advantage of prosthesis insertion.
    Théron A, Morera P, Resseguier N, Grisoli D, Norscini G, Riberi A, Collart F, Habib G, Avierinos JF.
    Arch Cardiovasc Dis; 2019 Feb; 112(2):95-103. PubMed ID: 30600216
    [Abstract] [Full Text] [Related]

  • 45. Preoperative left ventricular dimensions predict reverse remodeling following restrictive mitral annuloplasty in ischemic mitral regurgitation.
    Braun J, Bax JJ, Versteegh MI, Voigt PG, Holman ER, Klautz RJ, Boersma E, Dion RA.
    Eur J Cardiothorac Surg; 2005 May; 27(5):847-53. PubMed ID: 15848325
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Functional outcomes with Carillon device over 1 year in patients with functional mitral regurgitation of Grades 2+ to 4+: results from the REDUCE-FMR trial.
    Khan MS, Siddiqi TJ, Butler J, Friede T, Levy WC, Witte KK, Lipiecki J, Sievert H, Coats AJS.
    ESC Heart Fail; 2021 Apr; 8(2):872-878. PubMed ID: 33619896
    [Abstract] [Full Text] [Related]

  • 53. Cardiovascular Outcomes Assessment of the MitraClip in Patients with Heart Failure and Secondary Mitral Regurgitation: Design and rationale of the COAPT trial.
    Mack MJ, Abraham WT, Lindenfeld J, Bolling SF, Feldman TE, Grayburn PA, Kapadia SR, McCarthy PM, Lim DS, Udelson JE, Zile MR, Gammie JS, Gillinov AM, Glower DD, Heimansohn DA, Suri RM, Ellis JT, Shu Y, Kar S, Weissman NJ, Stone GW.
    Am Heart J; 2018 Nov; 205():1-11. PubMed ID: 30134187
    [Abstract] [Full Text] [Related]

  • 54. Percutaneous mitral valve repair for mitral regurgitation in high-risk patients: results of the EVEREST II study.
    Glower DD, Kar S, Trento A, Lim DS, Bajwa T, Quesada R, Whitlow PL, Rinaldi MJ, Grayburn P, Mack MJ, Mauri L, McCarthy PM, Feldman T.
    J Am Coll Cardiol; 2014 Jul 15; 64(2):172-81. PubMed ID: 25011722
    [Abstract] [Full Text] [Related]

  • 55. Subannular repair for functional mitral regurgitation with reduced systolic ventricle function: rationale and design of REFORM-MR registry.
    Girdauskas E, Pausch J, Reichenspurner H, Kempfert J, Kuntze T, Owais T, Holubec T, Krane M, Vitanova K, Borger M, Eden M, Hachaturyan V, Bramlage P, Falk V.
    J Cardiothorac Surg; 2022 Dec 30; 17(1):343. PubMed ID: 36581901
    [Abstract] [Full Text] [Related]

  • 56. Treatment of functional mitral regurgitation in chronic heart failure: can we get a 'proof of concept' from the MITRA-FR and COAPT trials?
    Senni M, Adamo M, Metra M, Alfieri O, Vahanian A.
    Eur J Heart Fail; 2019 Jul 30; 21(7):852-861. PubMed ID: 31116485
    [Abstract] [Full Text] [Related]

  • 57. Undersized annuloplasty for functional mitral regurgitation: is it responsible for clinically relevant mitral stenosis during exercise?
    Grimaldi A, De Bonis M, Pappalardo F, Taramasso M, Verzini A, Calabrese MC, Maisano F, Alfieri O.
    J Heart Valve Dis; 2012 Jul 30; 21(4):446-53. PubMed ID: 22953670
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Persistent reduction of mitral regurgitation by implantation of a transannular mitral bridge: durability and effectiveness of the repair at 2 years-results of a prospective trial†.
    Cerny S, Benesova M, Skalsky I, Patel NC, Subramanian VA.
    Eur J Cardiothorac Surg; 2019 May 01; 55(5):867-873. PubMed ID: 30590416
    [Abstract] [Full Text] [Related]

  • 60. Five-year outcomes of transcatheter reduction of significant mitral regurgitation in high-surgical-risk patients.
    Kar S, Feldman T, Qasim A, Trento A, Kapadia S, Pedersen W, Lim DS, Kipperman R, Smalling RW, Bajwa T, Hermann HC, Hermiller JB, Lasala JM, Reisman M, Glower D, Mauri L, Whitlow P, EVEREST II Investigators.
    Heart; 2019 Nov 01; 105(21):1622-1628. PubMed ID: 30077993
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.